American Well Corp (AMWL) - Q2 2025 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. American Well Corporation is a leading enterprise software company enabling digital delivery of care. The company operates as a single reporting segment, focusing on its "Converge" platform to facilitate hybrid care delivery for health systems, health plans, and government entities. The company is an accelerated filer with no debt outstanding.
Key Financial Metrics
| Metric (in thousands) | Q2 2025 (3 Months) | Q2 2024 (3 Months) | YTD 2025 (6 Months) | YTD 2024 (6 Months) |
|---|---|---|---|---|
| Revenue | $70,898 | $62,790 | $137,731 | $122,312 |
| Net Loss | $(19,531) | $(50,579) | $(37,887) | $(124,028) |
| Net Loss Attributable to AMWL | $(19,696) | $(49,920) | $(38,400) | $(122,025) |
| Loss Per Share (Basic/Diluted) | $(1.24) | $(3.36) | $(2.43) | $(8.28) |
| Operating Cash Flow | N/A | N/A | $(29,832) | $(81,549) |
| Cash and Equivalents | $219,072 | N/A | $219,072 | N/A |
| Total Debt | $0 | $0 | $0 | $0 |
Note: Operating cash flow is presented on a six-month basis as per the Statement of Cash Flows.
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 13% year-over-year for both the quarter and the six-month period. Subscription revenue grew significantly ($12.9M increase in Q2) due to timing of recognition with strategic customers. Visit revenue decreased due to the divestiture of the APC Business, partially offset by growth in virtual primary care.
- Expense Reduction: Total costs and operating expenses decreased 21% in Q2 and 25% YTD. This was driven by significant headcount reductions (22% in cost of revenue, 41% in sales and marketing) and reduced stock-based compensation.
- Divestiture: The company completed the sale of its Aligned Telehealth (APC) business in January 2025, recognizing a gain of $10.7 million in the first half of 2025. This transaction removed the telepsychiatry and correctional programs from the portfolio.
- Joint Venture Wind-down: The company determined its joint venture with Cleveland Clinic (CCAW, JV LLC) is no longer necessary and will wind down in the second half of 2025. The carrying value of this investment was reduced to zero by June 30, 2025.
Guidance, Outlook, and Risks
- Strategic Focus: Management is streamlining service offerings to focus resources on the Converge platform, strategic customers, and the path to profitability. The company expects R&D, Sales & Marketing, and G&A expenses to decrease in the current year and remain flat in future periods.
- Liquidity: The company holds $219.1 million in cash and cash equivalents. Management believes this is sufficient to meet working capital and capital expenditure needs for at least the next 12 months. No debt is outstanding.
- Key Risks:
- History of losses and risk of not achieving profitability.
- Concentration of revenue (two clients accounted for 50% and 12% of receivables as of June 30, 2025).
- Regulatory changes in healthcare reimbursement and privacy laws.
- Impact of the "One Big Beautiful Bill Act" (OBBBA) enacted in July 2025, which may impact future tax forecasts.
Investor Verification Checklist
- Revenue Quality: Verify the sustainability of the 13% revenue growth, specifically the portion attributed to "timing of revenue recognition" with strategic customers versus organic volume growth.
- Cost Structure: Confirm that the significant expense reductions (driven by headcount cuts) are sustainable and do not impair the company's ability to maintain the Converge platform or service existing clients.
- Client Concentration: Assess the risk associated with the top two clients representing 62% of outstanding accounts receivable.
- Divestiture Impact: Evaluate the long-term strategic impact of exiting the APC (telepsychiatry/correctional) market and the success of the remaining portfolio in replacing that revenue stream.
- Cash Burn: Monitor the operating cash burn rate ($29.8M for six months) against the $219M cash balance to validate the 12-month liquidity runway.